BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 15, 2003
View Archived Issues
Acambis Files 'First-Ever' BLA: Arilvax Vaccine In Yellow Fever
Acambis plc filed a biologics license application seeking approval of Arilvax as a vaccine to prevent yellow fever. (BioWorld Today)
Read More
Xanthus Series B Gets $30.8M To Advance Phase II Program
Read More
New-Found Proteins Cause Iron Overload Ailment In Body, But Presage Hemochromatosis Cure
Read More
VasGene Uses ASH Platform To Tout Anti-VEGF Cancer Product
Read More
Correction
Read More
Other News To Note
Read More
